1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-amine

Catalog No. :
ACPSKZ651
CAS No. :
149978-42-7
Molecular Formula :
C5H6F3N3
Molecular Weight :
165.12

IUPAC Name:1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-amine

1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$204.00Login to see priceIn stockInquiry
25g95%$784.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-amine
IUPAC Name1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-amine
MDL No.MFCD09701818
Molecular FormulaC5H6F3N3
Molecular Weight165.12
SMILESNC1=NN(C)C(C(F)(F)F)=C1
InChI KeyXIVVMPWSYHAGFP-UHFFFAOYSA-N
SynonymEN300-100132 | AMY6421 | DTXSID30628877 | 5-(Trifluoromethyl)-1-methyl-1H-pyrazol-3-amine | MFCD09701818 | SCHEMBL1012284 | FS-2343 | Z1198221261 | 1H-Pyrazol-3-amine, 1-methyl-5-(trifluoromethyl)- | 1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-amine | ZFA97
CAS No.149978-42-7
PubChem CID22912798

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPSKZ651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPSKZ651 route product structure diagram
    ACPSKZ651149978-42-7 In Stock
Inquiry

2. ACPSKZ651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBFSC511 route compound structure diagram
    ACBFSC51143086-58-4
  6. Then
  7. ACPSKZ651 route product structure diagram
    ACPSKZ651149978-42-7 In Stock
Inquiry

Comments (0)